[Outcome of Behçet disease in ophthalmologic practice in Morocco].
We treated 123 patients with Behçet's disease during a period of 10 years (1984-1993). The ocular lesions include uveal lesions especially the posterior lesions and vascular retinal. Uveitis was total in 72% of cases. Periphlebitis occurred in 51% of cases, vein occlusion in 10% of cases, macular oedema in 16% and papillary oedema in 10%. Clinical course and prognosis were studied. The functional prognosis is poor as such lesions may lead to blindness, particularly due to papillary oedema maculopathy. The treatment used is based on immunosuppressive and corticoid steroid drugs.
Ouazzani
B
B
Clinique Universitaire B, Hôpital des Spécialités, CHU, Rabat, Maroc.
Benchekroun
N
N
el Aouni
A
A
Hajji
Z
Z
Chaoui
Z
Z
Berraho-Hamani
A
A
D000328:Adult; D001528:Behcet Syndrome / Q000503:physiopathology* / Q000628:therapy; D002699:Chlorambucil / Q000627:therapeutic use; D016572:Cyclosporine / Q000627:therapeutic use; D005128:Eye Diseases / Q000503:physiopathology* / Q000628:therapy; D005260:Female; D006801:Humans; D008297:Male; D009018:Morocco; D011241:Prednisone / Q000627:therapeutic use; D011379:Prognosis; D012164:Retinal Diseases / Q000209:etiology / Q000503:physiopathology; D013997:Time Factors; D014605:Uveitis / Q000209:etiology / Q000503:physiopathology
D002699:Chlorambucil; D016572:Cyclosporine; D011241:Prednisone
Devenir de la maladie de Behçet en milieu ophtalmologique marocain.